About
CDSCO Drug Approval Process
Course Introduction
About this course
The CDSCO Drug Approval Process provides an overview of the regulatory pathway through which pharmaceutical products are evaluated and approved for marketing in India. The Central Drugs Standard Control Organization (CDSCO) serves as the national regulatory authority responsible for ensuring the safety, efficacy, and quality of drugs before they reach the public. Understanding the CDSCO approval framework is essential for professionals involved in pharmaceutical development, regulatory affairs, and clinical research.
The CDSCO (Central Drugs Standard Control Organization) drug approval process is the regulatory pathway that determines how new medicines enter the Indian market — combining safety review, clinical trial oversight, and approval mechanisms aligned with national and international standards.
This course builds foundational competence in the CDSCO drug approval process — covering regulatory submission requirements, clinical trial approvals, safety evaluation, and the approval workflow that determines drug market access in India.
🎯 Built for clinical readiness. Concise, structured, and skill-focused — designed to translate directly into safer, more confident clinical practice.
What this programme covers
Scope of the Course
What this course covers
The scope of this program includes the structure and role of CDSCO in drug regulation, the stages of drug approval in India, and the documentation required for regulatory submissions. It also covers investigational new drug applications, clinical trial approvals, new drug applications, regulatory review processes, and post-approval regulatory requirements. The program also highlights compliance with national and international regulatory standards.
🧠
Why this scope matters
This course builds foundational competence in the CDSCO drug approval process — covering regulatory submission requirements, clinical trial approvals, safety evaluation, and the approval workflow that determines drug market access in India.
Learning objectives
Course Objectives & Outcomes
What you will achieve
By the end of this course, learners will have built core clinical competencies directly applicable to everyday practice — translating into safer, more confident, more effective patient care.
Each outcome below targets a specific dimension of CDSCO regulatory practice — building the regulatory understanding required for confident drug approval pathway navigation.
By the end of this course, learners will be able to:
01
To understand the regulatory role and functions of CDSCO in India
02
To learn the step-by-step process of drug approval and regulatory submission
03
To understand documentation requirements and regulatory review procedures
04
To develop knowledge of clinical trial approval and new drug application processes
05
To prepare learners for roles in regulatory affairs, pharmaceutical development, and clinical research
Cleaner submissions. Sharper compliance. Faster approvals.
Build clinical confidence one skill at a time.
Who can enroll
Who Can Enroll
Built for these learners
This course is designed for healthcare learners and professionals seeking practical, skill-focused clinical training.
This course is built for pharmacy students, regulatory affairs professionals, clinical research staff, and pharmaceutical industry professionals working with Indian drug approvals.
Designed for these learners
🧑⚕️
01
Pharmacy students including B.Pharm, M.Pharm, Pharm.D
👨⚕️
02
Life science graduates
👩⚕️
03
Clinical research professionals
🦹
04
Healthcare practitioners interested in pharmaceutical regulation
💊
05
Individuals seeking foundational knowledge of drug regulatory approval processes in India
Sharper Skills. Stronger Practice.
Take the next step in your clinical journey with structured, skill-focused training.
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
CDSCO Drug Approval Process
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.